Inflazome UK Ltd.
🇬🇧United Kingdom
Clinical Trials
3
Active:0
Completed:2
Trial Phases
1 Phases
Phase 1:3
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Phase 1
3 (100.0%)PK Study in Patients With Parkinson's Disease With IZD174
- First Posted Date
- 2020-04-08
- Last Posted Date
- 2020-12-04
- Lead Sponsor
- Inflazome UK Ltd
- Registration Number
- NCT04338997
Safety and Tolerability, Pharmacokinetic and Pharmacodynamic Study With IZD334
Phase 1
Completed
- Conditions
- Healthy VolunteersCryopyrin Associated Periodic Syndrome
- Interventions
- Drug: Placebos
- First Posted Date
- 2019-09-11
- Last Posted Date
- 2020-03-02
- Lead Sponsor
- Inflazome UK Ltd
- Target Recruit Count
- 64
- Registration Number
- NCT04086602
- Locations
- 🇦🇺
Nucleus Network, Melbourne, Victoria, Australia
Safety and Tolerability, Pharmacokinetic and Pharmacodynamic Study With Inzomelid
- First Posted Date
- 2019-07-10
- Last Posted Date
- 2020-03-27
- Lead Sponsor
- Inflazome UK Ltd
- Target Recruit Count
- 80
- Registration Number
- NCT04015076
- Locations
- 🇦🇺
Nucleus Network, Melbourne, Queensland, Australia
News
No news found